Plasma pancreatic stone protein is a promising biomarker for prognosis and severity outcome in sepsis patients with COVID-19
Abstract Sepsis and coronavirus disease 2019 (COVID-19) are life-threatening clinical syndromes with high mortality rate. This study aimed to investigate pancreatic stone protein (PSP) role as potential biomarker for sepsis/COVID-19 prognostication. Herein, based on the novel amplified luminescent p...
| 出版年: | Scientific Reports |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Nature Portfolio
2025-10-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1038/s41598-025-09750-0 |
